Trademark Search  /  THERE'S NO CARE LIKE HOME

THERE'S NO CARE LIKE HOME

● Live · Registered

U.S. federal trademark · Serial No. 98170615 · Reg. No. 7605004

Mark
THERE'S NO CARE LIKE HOME
Status
Registered
Serial Number
98170615
Registration No.
7605004
Filing Date
September 8, 2023
Registration Date
December 17, 2024
Class(es)
Class 035, Class 042, Class 044, Class 045

Owners

Reimagine Care, Inc.
03 · Nashville, TN, US
Reimagine Care, Inc.
03 · Nashville, TN, US
Reimagine Care, Inc.
03 · Nashville, TN, US

Goods & Services

Arranging of contracts for clinical trials and value-based care contracts with third parties

Providing personal support services for patients and families of patients undergoing cancer treatment, namely, emotional counseling and emotional support through volunteers in the community who include cancer survivors, as well as family members and friends of cancer patients

Platform as a service (PAAS) featuring computer software platforms for providing oncology hospital at home technology-enabled services in the nature of monitoring medication administration and dosage, assessing and reporting on pain levels for supporting oncologists and other healthcare providers in delivering high-quality, lower-cost, patient-centric cancer care; conducting scientific research in the nature of clinical trials for others relating to medical devices and pharmaceuticals in the field of cancer diagnosis and treatment, namely, partnering with pharmaceutical companies and clinical research organizations (CROs) to administer and monitor oncology clinical trials at patients' homes, and provide clinical trial access to diverse patient populations for clinical trial participation, accelerate trial completion, and lower trial costs; Platform as a service (PAAS) featuring computer software platforms for monitoring, analyzing, assessing, transmitting patient medical and healthcare data to inform cancer care delivery optimization to patients and cancer care providers through a value-based care logistics management platform to efficiently and effectively manage workforce staffing, patient care, and pharmaceutical supplies required in alternative cancer delivery models; Platform as a service (PAAS) featuring computer software platforms for providing a comprehensive oncology clinical management solution, namely, medication administration and management, supportive care, lab testing, pain management, day-after-chemo injection of colony-stimulating factor drugs, advanced care planning, and at-home palliative care; Platform as a service (PAAS) featuring computer software platforms for providing cancer patients extensive cancer care navigation services in the nature of providing coordinated care by assessing, triaging, follow-up and supporting patients 24/7 and on-demand, for keeping patients with compromised immune function out of institutional settings and treating them in the convenience of their homes

Analysis of oncology medical information for the treatment of cancer in the home on behalf of patients and cancer care providers, namely, medical record analysis of value-based care, care coordination, decision-making services, and insights in the nature of severity of patients' symptoms, as well as the evaluation of medical information from oncology clinical research studies for determining patient access and participation in clinical trials for the treatment of cancer; medical services in the field of oncology, namely, providing oncology infusion therapy and oral oncolytic in alternative settings; medical services, namely, providing real-time symptom management and telemedicine triage via a dedicated multi-disciplinary oncology care team to optimize adverse cancer patient events and reactions to cancer

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "THERE'S NO CARE LIKE HOME" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.